Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Published on by Forensic Scientist

Prof. Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Minhang Hospital, Fudan University | China

Prof. Yuyan Tang is a clinician-scientist specializing in nephrology and molecular immunopathology, with a strong research focus on the gut–kidney axis, IgA nephropathy, and chronic kidney disease (CKD). Her studies elucidate the mechanisms by which intestinal microbiota, short-chain fatty acids (SCFAs), and NLRP3 inflammasome signaling influence renal inflammation and fibrosis, integrating molecular biology with traditional Chinese medicine interventions. She has led several competitive research projects funded by the National Natural Science Foundation of China and regional scientific bodies, advancing translational insights into renal disease mechanisms and microbiome-based therapeutic strategies. Prof. Yuyan Tang has published 23 peer-reviewed documents indexed in Scopus, garnering 287 citations across 262 citing documents, with an h-index of 8. Her scientific contributions include 8 first- or corresponding-author SCI papers with a total impact factor of 52.7, notably featuring a highly cited article in Circulation Research and impactful publications in Nephrology Dialysis Transplantation and BMC Microbiology. Recognized as a Youth Talent Awardee at Fudan University’s Affiliated Minhang Hospital, Prof. Yuyan Tang’s research continues to bridge microbiome regulation and nephrology through innovative molecular and clinical investigations.

Profile: Scopus

Featured Publications

  • Tang, Y., Zhu, Y., He, H., Sun, W., Wu, J., Xiao, Y., … Xu, X. (2024). IgA nephropathy: Gut microbiome regulates the production of hypoglycosylated IgA1 via the TLR4 signaling pathway. Nephrology Dialysis Transplantation, 39(10), 1624–1641.

  • Jiang, L., He, H., Tang, Y., Li, J., Reilly, S., Xin, H., … Cai, H. (2024). Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy. Autophagy, 20(11), 2388–2404.

  • Li, H., Xu, M., Xu, X., Tang, Y., Jiang, H., Li, L., … Yang, T. (2022). Faecalibacterium prausnitzii attenuates CKD via Butyrate-Renal GPR43 Axis. Circulation Research, 131(9), e120–e134.

  • Tang, Y., Xiao, Y., He, H., Zhu, Y., Sun, W., Hu, P., … Xu, X. (2023). Aberrant gut microbiome contributes to barrier dysfunction, inflammation and local immune responses in IgA nephropathy. Kidney and Blood Pressure Research, 48(1), 261–276.

  • Tang, Y., Zhu, Y., He, H., Peng, Y., Hu, P., Wu, J., … Xu, X. (2022). Gut dysbiosis and intestinal barrier dysfunction promote IgA nephropathy by increasing the production of Gd-IgA1. Frontiers in Medicine, 9, 944027.

Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Published on by Forensic Scientist

Mrs. Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University | Poland

Mrs. Monika Prylińska-Jaśkowiak is an emerging clinician-scientist whose professional journey reflects a rare balance between medical practice, academic excellence, and translational research. She earned her Doctor of Medical Sciences degree from Collegium Medicum, Nicolaus Copernicus University in Toruń, where her doctoral research focused on the relationship between the gut microbiome and chronic fatigue syndrome, integrating clinical insight with advanced molecular and bioinformatic analyses. As a specialist pediatrician at the Voivodeship Children’s Hospital in Bydgoszcz, she combines her research background with everyday patient care and is currently pursuing specialization in pediatric rheumatology. Her scientific contributions include peer-reviewed publications such as The gut microbial composition is different in chronic fatigue syndrome than in healthy controls (Scientific Reports, 2025), and review papers in the Journal of Education, Health and Sport (2022), widely cited for summarizing current knowledge on CFS/ME and human gut microbiota. Mrs. Monika Prylińska-Jaśkowiak’s research interests encompass pediatric immunology, microbiome–immune interactions, and chronic inflammatory diseases, with a focus on precision diagnostics and targeted therapy development. Actively engaged in professional societies including the Polish Pediatric Society and the Polish Society of Vaccinology, she continues to expand her expertise through certified courses in resuscitation, vaccinology, and emergency pediatrics. Her commitment to continuous learning, clinical excellence, and evidence-based innovation exemplifies the spirit of a modern physician-scientist dedicated to improving child health and advancing medical science.

Profile: ORCID | LinkedIn

Featured Publications

• Prylińska, M., & Kożuchowski, M. (2022, September 28). The human gastrointestinal tract microbiota in health – current knowledge summary. Journal of Education, Health and Sport, 12(10). https://doi.org/10.12775/JEHS.2022.12.10.005

• Kożuchowski, M., & Prylińska, M. (2022, April 30). The proper functioning of the sense of smell and its disturbances on the example of COVID-19 infection. Journal of Education, Health and Sport, 12(4). https://doi.org/10.12775/JEHS.2022.12.04.026

Omur Baysal | Microbiology | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Omur Baysal | Microbiology | Best Researcher Award

Mugla Sitki Kocman University | Turkey

Prof. Dr. Ömür Baysal is a tenured researcher in Molecular Microbiology at Muğla University (Turkey) and an Honorary Professor at the University of Worcester (UK). His work focuses on host-microbe interactions, molecular markers, biological control of pathogens, antibiotic resistance, and bioinformatics (genomics, proteomics, drug discovery). With an H-index of 20, he bridges lab research and computational biology.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  1. High-Impact Research Output

    • Extensive Publications: Over 35+ SCI/SCI-E indexed journal articles, demonstrating consistent contributions to molecular microbiology, plant-pathogen interactions, and bioinformatics.

    • Diverse Research Areas: Expertise spans host-microbe interactions, antibiotic resistance, biocontrol agents, drug discovery, and omics technologies (genomics, proteomics, metagenomics).

    • Recent High-Profile Works (2023-2024):

      • Anticancer Agents in Medical Chemistry (2024) – Machine learning & cancer research.

      • PLoS ONE (2021) – Computational analysis of SARS-CoV-2.

      • Frontiers in Oncology (2023) – Cold plasma therapy in cancer.

  2. International Collaborations & Recognition

    • Honorary Professorship (UK): Affiliation with the University of Worcester strengthens global research ties.

    • Sabbaticals & Invited Research Roles: Worked at USDA/USA, Volcani Center (Israel), CNR (Italy), CIRAD (France), indicating international recognition.

    • Multi-Country Co-Authorships: Collaborations with researchers from Germany, Israel, Italy, UK, Belarus, etc.

  3. Innovative Methodologies

    • Bioinformatics & AI Integration: Use of machine learning, molecular docking, RNA-seq, and metagenomics in pathogen studies.

    • Biocontrol & Sustainable Agriculture: Focus on biological control agents (Bacillus spp.) and host-induced gene silencing (HIGS).

    • Translational Research: Applied studies on drug discovery (HIV-1, breast cancer, SARS-CoV-2).

  4. Strong Academic Metrics

    • H-index: 20 | I-index: 31 (Google Scholar) – Reflects sustained citation impact.

    • Editorial Roles: Serves as a referee for Frontiers in Microbiology, PLOS ONE, Plant Disease (APS), etc.

Education 🎓

  • B.Sc. (1994): Plant Protection Engineering, Akdeniz University, Turkey.

  • M.Sc. (1997): Phytopathology, Akdeniz University.

  • Ph.D. (2001): Plant Pathology (Bacteriology), University of Göttingen, Germany.

  • Postdoc Training (2007–2014): Volcani Center (Israel), CNR Italy, CIRAD France, USDA/University of Florida (USA).

Experience 💼

  • Current Roles:

    • Professor, Molecular Microbiology & Bioinformatics, Muğla University.

    • Honorary Professor, Biosciences, University of Worcester (UK).

  • Expertise: Molecular diagnostics, biocontrol agents, recombinant DNA, protein-ligand docking, and whole-genome/RNA-seq analysis.

Research Interests On Microbiology 🔍

  • Host-microbe interactions

  • Antibiotic resistance mechanisms

  • Biological control of plant pathogens

  • Bioinformatics (genomics, metagenomics, drug discovery)

  • Enzyme enhancement via recombinant tech

Awards & Honors 🏆

  • High-impact publications (31+ SCI-indexed papers).

  • International collaborations (US, EU, Israel).

  • Editorial roles in Frontiers in Microbiology, PLoS ONE, Plant Pathology, etc.

Publications 📚

  • Title: Induction of defence‐related enzymes and resistance by the plant activator acibenzolar‐S‐methyl in tomato seedlings against bacterial canker caused by Clavibacter michiganensis
    Authors: Ö Baysal, EM Soylu, S Soylu
    Year: 2003
    Cited by: 227

  • Title: Induction of disease resistance by the plant activator, acibenzolar-S-methyl (ASM), against bacterial canker (Clavibacter michiganensis subsp. michiganensis) in tomato seedlings
    Authors: S Soylu, Ö Baysal, EM Soylu
    Year: 2003
    Cited by: 164

  • Title: An inhibitory effect of a new Bacillus subtilis strain (EU07) against Fusarium oxysporum f. sp. radicis-lycopersici
    Authors: Ö Baysal, M Çalışkan, Ö Yeşilova
    Year: 2008
    Cited by: 151

  • Title: A Proteomic Approach Provides New Insights into the Control of Soil-Borne Plant Pathogens by Bacillus Species
    Authors: Ö Baysal, D Lai, HH Xu, M Siragusa, M Çalışkan, F Carimi, JAT Da Silva, …
    Year: 2013
    Cited by: 124

  • Title: Molecular Characterization of Fusarium oxysporum f. melongenae by ISSR and RAPD Markers on Eggplant
    Authors: Ö Baysal, M Siragusa, E Gümrükcü, S Zengin, F Carimi, M Sajeva, …
    Year: 2010
    Cited by: 112

  • Title: Chemical composition and antifungal activity of the essential oil of Artemisia annua L. against foliar and soil-borne fungal pathogens
    Authors: EM Soylu, H Yiğitbaş, FM Tok, S Soylu, Ş Kurt, Ö Baysal, AD Kaya
    Year: 2005
    Cited by: 109

  • Title: Induction of oxidants in tomato leaves treated with DL-β-Amino butyric acid (BABA) and infected with Clavibacter michiganensis ssp. michiganensis
    Authors: Ö Baysal, YZ Gürsoy, H Örnek, A Duru
    Year: 2005
    Cited by: 108

  • Title: Acibenzolar-S-methyl induced resistance to Phytophthora capsici in pepper leaves
    Authors: O Baysal, C Turgut, G Mao
    Year: 2005
    Cited by: 75

  • Title: Extract of Hedera helix induces resistance on apple rootstock M26 similar to Acibenzolar-S-methyl against Fire Blight (Erwinia amylovora)
    Authors: Ö Baysal, W Zeller
    Year: 2004
    Cited by: 67

  • Title: Fusarium oxysporum f. sp. lycopersici races and their genetic discrimination by molecular markers in West Mediterranean region of Turkey
    Authors: Ö Baysal, M Siragusa, H İkten, İ Polat, E Gümrükcü, F Yigit, F Carimi, …
    Year: 2009
    Cited by: 61

Conclusion 🌟

Prof. Baysal is a pioneer in molecular plant-microbe interactions, blending wet-lab and computational tools. His work on biocontrol agents, antibiotic resistance, and drug discovery has global impact, supported by international collaborations and high-profile publications. A leader in both academia and applied research.

Fizza Khalid | microbiology | Best Researchrer Award

Published on by Forensic Scientist

Dr. Fizza Khalid | microbiology | Best Researcher Award

clinical scientist at Dr Sulaiman Al-Habib Medical Diagnostic Laboratory , Saudi Arabia

Dr. Fizza Khalid is a dedicated microbiologist with extensive expertise in laboratory research, antimicrobial resistance, and clinical microbiology. With a Ph.D. in Medical Microbiology from the University of Health Sciences, Lahore, she has a proven track record of characterizing drug-resistant bacteria and developing innovative treatment strategies. Currently, she is the Deputy Head of the Clinical Research Committee and a Specialized Lab Supervisor at MD Lab, Dr. Sulaiman AlHabib Medical Group, Saudi Arabia. Dr. Khalid is passionate about advancing microbiological research to improve healthcare outcomes and has published several impactful studies in leading international journals.

Profile

ORCID

Educational

  • Ph.D. in Medical Microbiology (2016–2023) – University of Health Sciences, Lahore
    Thesis: Characterization of Locally Isolated Acinetobacter baumannii Strains for Drug Resistance and Biofilm Formation
  • M.Phil. in Medical Microbiology (2012–2014) – University of Health Sciences, Lahore
    Thesis: In-vitro Efficacy of Polymyxin B with Rifampin, Colistin, and Doxycycline Against Extensively Drug Resistant Acinetobacter baumannii
  • M.Sc. in Medical Technology (2008–2010) – University of Health Sciences, Lahore
    Thesis: Frequency of Extended Spectrum Beta Lactamase Enzymes in the Clinical Isolates of Salmonella Typhi
  • B.Sc. in Medical Laboratory Technology (2005–2007) – University of Health Sciences, Lahore

Professional Experience

Dr. Fizza Khalid currently serves as the Deputy Head of the Clinical Research Committee and Specialized Lab Supervisor in Microbiology at MD Lab, Dr. Sulaiman AlHabib Medical Group, Saudi Arabia. In her role, she leads clinical microbiology operations, collaborates with healthcare professionals, ensures regulatory compliance, and conducts research presented at international conferences. Previously, she was a Senior Lab Technologist at the same group, where she developed standard operating protocols, performed clinical microbiology analysis, and ensured testing quality and safety compliance. Throughout her career, Dr. Khalid has mentored junior researchers, promoted clinical research, and conducted workshops to enhance scientific study design and writing skills.

Research Interests

Dr. Khalid’s research focuses on antimicrobial resistance, particularly in Acinetobacter baum                                                                                             annii and Salmonella Typhi, biofilm formation, and the effectiveness of novel treatment strategies against drug-resistant bacterial strains. She has a keen interest in developing antimicrobial agents, studying bacterial genotyping, and investigating synergistic antibiotic combinations to combat multidrug-resistant pathogens. Her research contributes to understanding the molecular mechanisms of resistance and finding practical applications for improving patient care in clinical settings.

Author Metrics

  • Published Papers: 14 peer-reviewed articles, including journals such as Clinica Chimica Acta, JPMA, Scientific Reports, and Annals of Clinical Microbiology and Antimicrobials.
  • Citations: Her work has been widely cited in the fields of antimicrobial resistance and biofilm research.
  • H-index: Reflects her contributions to microbiology, particularly in research related to Acinetobacter baumannii and Salmonella Typhi.

Publication

Conclusion

Fizza Khalid presents an excellent case for the Best Researcher Award in medical microbiology, with notable strengths in antibiotic resistance research, an impressive publication record, and practical lab expertise. Her leadership role in facilitating junior researchers and fostering a culture of research also speaks to her broader contribution to the scientific community. With a few targeted improvements, such as securing international collaborations and focusing her research scope, she can further strengthen her candidacy for the award.

In conclusion, Khalid’s achievements in medical microbiology, particularly her work on MDR pathogens, make her a strong contender for the Best Researcher Award, demonstrating both scientific excellence and leadership in her field.